skip to Main Content

Ipreo Quarterly US Update: Quarter Ending December 31, 2016

In total, Q4 saw 184 deals for $48.8B in proceeds, slightly below of Q3’s 191 deals for $65.0B in proceeds. However, the quarter outpaced the 129 deals for $43.0B seen in prior-year period. Separately, the quarter’s IPO deal count increased to 25 for $7.2B in proceeds, just above (in terms in proceeds) the prior quarter’s 26 deals and $5.9B in proceeds. Finally, Q4 follow-ons and block trades accounted for 141 of the total deals for the quarter and generated $36.4B.

Ipreo Quarterly US Update: Quarter Ending September 30, 2016

In total, Q3 saw 191 deals for $65.0B in proceeds, slightly ahead of Q2’s 182 deals for $55.2B in proceeds; additionally, the quarter outperformed the 154 deals for $38.3B seen in Q3 2015. Separately, the quarter’s IPO deal count increased to 31 for $6.2B in proceeds, just above the prior quarter’s 26 deals and $5.9B in proceeds. Finally, Q3 follow-ons and block trades accounted for 133 of the total deals for the quarter and generated $43.7B.

Ipreo Quarterly US Update: Quarter Ending June 30, 2016

The second quarter of 2016 saw a total of 182 deals come to market for proceeds of $55.2B, an uptick from the first quarter’s 108 deals for $40.7B but a significant decline from the prior-year period’s 276 deals for $80.9B. Furthermore, the second quarter saw a sizable jump in IPO as 26 new issuers made their market debuts and generated $5.9B in proceeds, following a dismal first quarter in which just 6 issuers made their public debuts for $569.6M.

Ipreo Quarterly US Update: Quarter Ending March 31, 2016

The new issuance market began the year down on proceeds and deals count from the prior quarter. In total, Q1 saw 108 deals for $40.7B in proceeds, less than Q4’s 129 deals for $43.0B. Also, the quarter paled in comparison to the 265 deals for $90.5B seen in Q1 2015.  Furthermore, the quarter’s IPO deal count fell to 6 for $569.6M in proceeds, well below the prior-year period’s 31 deals for $5.6B.

Ipreo Quarterly US Update: Quarter ending September 30, 2015

Healthcare, once again, proved to be a dominant force for new issuance in Q3 2015, contributing 64 deals for a total of $10.2B in proceeds and accounting for over a third of the quarter’s volume. In the past, we have continually referenced the impressive streak the sector is on, but within this piece we take a closer look at Healthcare deals since 2005 to frame the rise of the sector in today’s market.

Ipreo Quarterly US Update: Quarter ending March 31, 2015

Since 2001, a total of 351 internationally-domiciled issuers have listed new shares on U.S. exchanges, accounting for 16.9% of all U.S.-listed IPOs over that timeframe (Figure 1). In this piece, we examine trends among these issuers, including the Chinese Consumer and Tech sectors, as well as the relatively nascent Israeli Healthcare industry. Additionally, we highlight recent ownership trends of non-U.S.-domiciled issuers as well as broader ownership trends for international IPOs.
Back To Top